Has company given any guidence for FY-25.
In terms of sales and opm and bottom-line.
At this juncture stock looks intresting and nicely priced.
Did go through transcripts and earning calls, could not find a guidence for FY25.
Their estimate for FY-24 stands at 8-9% topline growth.
Anyone with an idea, please comment?
https://twitter.com/kiranshaw/status/1768445810314772600?s=46
6 Crores seen in Electoral bonds revelation.
Please let us know if you can find the EB purchase by KMS in her personal capacity , soon after the bribery case where their staff had bribed or was black mailed by the Drug admin dept. for clearing their files. More like black mail as they already had approvals from all global regulators
This electoral bond issue is just entertainment… little to do with Business …
Though this is old news, I want to know the implications of Biocon biologics involvement with bribery case.
Government grants sanction to prosecute Drugs controller Mr.Reddy. He is suspended but the suspension is revoked as per this news article.
My question is how to trust Biocon, if they have not bribed for other products too. Maybe this is why the company’s marketcap is so low.
What is the current status of this case…Can anyone update.
Hello
Case will carry on with its pace. Impact on Biocon as a company will be limited …
